The quantification of p-eIF2α immunoreactivity showed a significant increase in the percentage of p-eIF2α + neurons for AD cases for all regions (Fig. 3b, Additional file 3: Supplementary Table 1). Here, EIF2A is linked to Alzheimer disease.